QUINAPRIL/HYDROCHLOROTHIAZID AUROBINDO

10MG/12,5MG TBL FLM 90

SÚKL code 0127869
Name of the product QUINAPRIL/HYDROCHLOROTHIAZID AUROBINDO 10 MG/12,5 MG POTAHOVANÉ TBL.
_MA_MEDICATION_DETAIL_INFO_MED_NAME i QUINAPRIL/HYDROCHLOROTHIAZID AUROBINDO
Supplement 10MG/12,5MG TBL FLM 90
Strenght 10MG/12,5MG
Pharmaceutical form Film-coated tablet
Package 90
Route Oral use
Language of the pack Czech
Wrap type Blister
Legal status na lékařský předpis
Active substance HYDROCHLOROTHIAZIDE (HYDROCHLOROTHIAZIDUM)
QUINAPRIL HYDROCHLORIDE (QUINAPRILI HYDROCHLORIDUM)
ATC group C09BA06
ATC group name CHINAPRIL A DIURETIKA
Doping Diuretika a ostatní maskovací látky (nelze pro léčbu sportovců použít vůbec). Bližší informace viz http://www.antidoping.cz/.

Marketing authorisation information

Registration Number 58/ 511/10-C
Type of MA A mutual recognition procedure (MRP, DCP), where CZ is Concerned member state
MA status B - medicinal product after change, may be placed on the market for the period of 6 months (Placed on the market till) and used until expiration, not later than till the end of validity of the marketing authorisation (Valid till)
Placed on the market till 31. 05. 2018
MA Holder Aurobindo Pharma Limited, South Ruislip
MA Holder country VELKÁ BRITÁNIE
Actual MA holder Aurovitas Pharma Polska Sp. z o.o., Warszawa
Actual MA holder country POLSKO

Back to list